Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by CleverInvestor2on Jan 23, 2020 6:55pm
114 Views
Post# 30591460

RE:Irrational Euphoria

RE:Irrational EuphoriaSmart money gets a discount, big money gets a discount. Unlike you, I see this offering as good news. It wasn't too long ago when we had to raise money below $1.
It wasn't too long ago before people said we were going bankrupt.
Our medication is now punching above it's weight, bringing in lots of new investors.

We needed money and it was only a matter of time before we had to do another offering to raise cash, the fact that we got 100M at $2.75USD just reaffirms that we are here to stay. 100M should be able to buy us another year worth of time, and hopefully by than we have more news on CD47 and TTI-621. If the drug is as successful as promsied, we'll be trading above $10USD in no time. Other competitors are worth Billons with inferior medicine.

If our drugs turn out to be duds, well, I'll see that coming and I'll sell for a massive profit since I have an average below 80Cents US. Yes, there's risk in this stock (like any other) but, I see more upside than downside right now, and it worth the risk in my opinion at these levels and with all the news available to us as of today.

I think the next big NR will come in May/June when they release an update on the drugs.

88guy88 wrote: yup....that explains it......offering at $3.62 Canadian value and its trading at over $5.00...go figure....just don't get caught when they all run for the exit....


<< Previous
Bullboard Posts
Next >>